Regarding 23andMe, I'd reconsider that view. They are sitting on a treasure trove of medical and genetic data. And they have begun to monetize this data, which

Regarding 23andMe, I'd reconsider that view. They are sitting on a treasure trove of medical and genetic data. And they have begun to monetize this data, which I believe was their endgame all along. More here: http://www.forbes.com/sites/matthewherper/2015/01/06/surprise-with-60-million-genentech-deal-23andme-has-a-business-plan/ http://www.forbes.com/sites/matthewherper/2015/01/06/surpris...